4/A//SEC Filing
Graham G. Walmsley 4/A
Accession 0000935836-24-000744
CIK 0001750284other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:48 PM ET
Size
7.8 KB
Accession
0000935836-24-000744
Insider Transaction Report
Form 4/AAmended
Graham G. Walmsley
Director
Transactions
- Sale
Common Stock
2024-06-04$14.85/sh−700,000$10,395,000→ 700,761 total(indirect: See note) - Sale
Common Stock
2024-06-04$14.85/sh−475,000$7,053,750→ 708,114 total(indirect: See note)
Footnotes (2)
- [F1]The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F2]The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:48 PM ET
- Size
- 7.8 KB